Profiling and Selecting Your Optimal Clinical Development Candidate
An educational webinar on mitigating risk of failure in drug development
View our webinar on INDiGO-Select, our characterization package to increase the knowledge on new chemical entities that are approaching the development phase.
INDiGO-Select is focused on the lead molecule chemistry, its physical-chemical properties and preclinical DMPK and safety profile, as to minimize the risk of failure during transition into the subsequent development stages, thus maximizing probability of success and minimizing overall development costs and timelines.
The webinar covers a description of the approach, showing the main benefits and case studies where this approach was successfully applied, leading to a 100% track record in identifying liabilities – no programs stopped due to tox or developability issues.
About the Speakers
If the video has not loaded above, please click here.